Refractory depression: Treatment strategies, with particular reference to the thyroid axis

Journal of Psychiatry and Neuroscience

Volumn 22, Issue 5, 1997, Pages 327-331

  Joffe, Russell T ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; LIOTHYRONINE; LITHIUM; PINDOLOL; PLACEBO; SEROTONIN 1A AGONIST; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; MENTAL DISEASE; META ANALYSIS; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

DEPRESSIVE DISORDER; DRUG RESISTANCE; HUMANS; RECURRENCE; THYROID GLAND; TRIIODOTHYRONINE;

EID: 0031442249     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Mueller TI, Keller MB, Leon AC, Salomon DA, Schea MT, Coryell W, et al. Recovery after five years of unremitting major depressive disorder. Arch Gen Psychiatry 1996;53:794-9.
2. Keller MB. Depression: a long-term illness. Br J Psychiatry 1994;165(suppl 26):9-15.
3. Keller MB, Levori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, et al. Time to recovery, chronicity and levels of psychopathology in major depression: a five-year perspective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49:809-16.
4. Keller MB, Levori PW, Wright J, Coryell W, Hirschfeld RMA. The persistent risk of chronicity in recurrent episodes of non-bipolar major depressive disorder: a prospective follow-up. Am J Psychiatry 1986;143:24-8.
5. Joffe RT, Levitt AJ. Antidepressant failure: augmentational substitution? J Psychiatry Neurosci 1995;15:7-9.
6. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996;2:179-98.
7. Price LH. Lithium augmentation tricyclic-resistant depression. In: Extein IL, editor. Treatment of tricyclic-resistant depression. Washington: American Psychiatric Press; 1988: p. 27-48.
8. Phillips KA, Nierenberg AA. The assessment and treatment of refractory depression. J Clin Psychiatry 1994;55:20-6.
9. 3 or lithium in resistant depression? J Clin Psychopharmacol 1989;9:73.
10. Joffe RT, Singer W, Levitt AJ, MacDonald C. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993;50:387-93.
11. Joffe RT, Singer W. A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res 1990;32:241-51.
12. de Montigny C, Cournoyer G, Morisette R, Langlois R, Cailler G. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression: correlations with the neurobiologic actions of tricyclic antidepressant drugs in lithium ion on the serotonin system. Arch Gen Psychiatry 1983;40:1327-33.
13. Dinan TG, Barry S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic non-responders. Acta Psychiatr Scand 1989;80:97-100.
14. Heninger GR, Charney DS, Sterberg DE. Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 1983;40:1335-42.
15. Ontiveros A, Fontaine R, Elie R. Refractory depression: the addition of lithium to fluoxerine or desipramine. Acta Psychiatr Scand 1991;83:188-92.
16. Price LH, Charney DS, Heninger GR. Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 1986;143:1387-92.
17. Schopf J, Bauman P, Lemarchand T, Ray M. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition: results of a placebo-controlled double-blind study. Pharmacopsychiatry 1989;22:183-7.
18. Thase ME, Kupfer DJ, Jarrett DB. Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine. J Clin Psychiatry 1989;50:385-8.
19. Austin MPV, Souza FGM, Goodwin GM. Lithium augmentation in antidepressant-resistant patients: a quantitative analysis. Br J Psychiatry 1991;159:510-4.
20. Jacobsen FM. Possible augmentation of antidepressant response by buspirone. J Clin Psychiatry 1991;52:217-20.
21. Joffe RT, Schuller DR. An open study of buspirone augmentation of serotonin re-uptake inhibitors in refractory depression. J Clin Psychiatry 1993;54:269-71.
22. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995;15:217-22.
23. Flach FF, Celian CI, Rawson RW. Treatment of psychiatric disorders with triiodothyronine. Am J Psychiatry 1958;114:841-6.
24. Feldmesser-Reiss EE. The application of triiodothyronine in the treatment of mental disorders. J Nerv Ment Dis 1958;127:540-3.
25. Prange AJ Jr, Wilson IC, Raybon SM, Lipton MA. Enhancement of the imipramine antidepressant activity by thyroid hormone. Am J Psychiatry 1969;12:457-69.
26. Wheatley D. Potentiation of amitriptyline by thyroid hormone. Arch Gen Psychiatry 1972;26:229-33.
27. Banki CM. Triiodothyronine in the treatment of depression. Orv Hetil 1975;116:2543-7.
28. Banki CM. Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women. Eur J Clin Pharmacol 1977;11:301-15.
29. Earle BV. Thyroid hormone in tricyclic antidepressants in resistant depression. Am J Psychiatry 1970;126:1667-9.
30. Goodwin FK, Prange AJ Jrs, Post RM, Muscettola G, Lipton AM. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic non-responders. Am J Psychiatry 1982;139:34-8.
31. Gitlin MJ, Weiner H, Fairbanks L, Herschman JM, Friedfeld N. Failure of T3 to potentiate tricyclic antidepressant response. J Affect Disord 1987;13:267-72.
32. Ogura C, Okuma T, Uchida Y, Imia S, Yogi H. Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states. Folia Psychiatr Neurol Jpn 1974;28:189-96.
33. Schwarcz G, Halaris A, Baxter L, Escobar J, Thompson M, Young M. Normal thyroid function in desipramine non-responders converted to responders by the addition of L-triiodothyronine. Am J Psychiatry 1984;141:1614-6.
34. Tsutsui S, Tamazaki Y, Namba T. Combined therapy of T3 and antidepressants in depression. J Int Med Res 1979;7:138-46.
35. Aronson R, Offman HJ, Joffe RT, Naylor CD. Triiodothyronine augmentation in the treatment of refractory depression: a meta-analysis. Arch Gen Psychiatry 1996;53:842-8.